Mortality Among Antiretroviral-Eligible Patients in an Urban Public Clinic
Author(s) -
David W. Dowdy,
Elvin Geng,
Katerina Christopoulos,
James S. Kahn,
C. Bradley Hare,
Daniel Wlodarczyk,
Diane V. Havlir
Publication year - 2011
Publication title -
jaids journal of acquired immune deficiency syndromes
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 2.162
H-Index - 157
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/qai.0b013e31822233aa
Subject(s) - medicine , antiretroviral therapy , human immunodeficiency virus (hiv) , public health , environmental health , pediatrics , family medicine , viral load , pathology
Advances in antiretroviral therapy (ART) over the last decade have improved clinical outcomes for people living with human immunodeficiency virus (HIV), but whether these improvements are experienced by disadvantaged urban populations is less clear.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom